Bank of Montreal Can Has $486.91 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank of Montreal Can decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,093,955 shares of the medical equipment provider’s stock after selling 35,037 shares during the quarter. Bank of Montreal Can owned approximately 0.31% of Intuitive Surgical worth $486,908,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Creekmur Asset Management LLC grew its stake in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical in the 2nd quarter valued at $26,000. Able Wealth Management LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at $28,000. Delos Wealth Advisors LLC grew its stake in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the last quarter. Finally, LRI Investments LLC acquired a new position in Intuitive Surgical in the 1st quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Mark Brosius sold 2,115 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the completion of the transaction, the insider now owns 295 shares in the company, valued at $145,113.45. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock worth $25,528,753 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ISRG. Citigroup raised their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Evercore ISI lowered their target price on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a research note on Friday, July 19th. Piper Sandler increased their price target on shares of Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Finally, JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $446.45.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $486.20 on Monday. The company has a 50-day moving average of $468.01 and a 200-day moving average of $425.38. The company has a market capitalization of $172.46 billion, a price-to-earnings ratio of 87.76, a PEG ratio of 5.41 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $496.18.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.18 earnings per share. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.